Nancy Brewig

411 total citations
7 papers, 338 citations indexed

About

Nancy Brewig is a scholar working on Immunology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Nancy Brewig has authored 7 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 2 papers in Oncology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Nancy Brewig's work include Immunotherapy and Immune Responses (3 papers), T-cell and B-cell Immunology (2 papers) and Immune Cell Function and Interaction (2 papers). Nancy Brewig is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), T-cell and B-cell Immunology (2 papers) and Immune Cell Function and Interaction (2 papers). Nancy Brewig collaborates with scholars based in United Kingdom, Germany and United States. Nancy Brewig's co-authors include Sadaf Ghaem‐Maghami, Lynsey M. Whilding, Uwe Ritter, Bernhard Fleischer, Thomas Bickert, Claudia Hayford, Andrew J.T. George, Christian J. Maine, Jayanta Chatterjee and Nor Haslinda Abd Aziz and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Immunology Immunotherapy.

In The Last Decade

Nancy Brewig

7 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Brewig United Kingdom 7 210 188 47 44 30 7 338
Laure Loumagne France 4 286 1.4× 183 1.0× 56 1.2× 27 0.6× 20 0.7× 4 358
Tsutomu Kamisako Japan 10 283 1.3× 141 0.8× 105 2.2× 27 0.6× 13 0.4× 15 467
Marie-Françoise Avril France 5 244 1.2× 288 1.5× 80 1.7× 20 0.5× 25 0.8× 5 411
Seungwon Lee South Korea 11 147 0.7× 75 0.4× 115 2.4× 20 0.5× 21 0.7× 17 316
Sylvain Bercegeay France 12 247 1.2× 190 1.0× 85 1.8× 54 1.2× 13 0.4× 17 384
P C de Wilde Netherlands 9 118 0.6× 129 0.7× 62 1.3× 18 0.4× 12 0.4× 11 361
Tiziano Ingegnere Italy 11 391 1.9× 280 1.5× 161 3.4× 16 0.4× 40 1.3× 15 604
Chungyong Han South Korea 11 166 0.8× 138 0.7× 107 2.3× 10 0.2× 27 0.9× 20 309
Kenzo Ohara Japan 12 406 1.9× 274 1.5× 167 3.6× 14 0.3× 27 0.9× 36 553
Michael R. Nazareth United States 8 181 0.9× 212 1.1× 75 1.6× 20 0.5× 12 0.4× 14 393

Countries citing papers authored by Nancy Brewig

Since Specialization
Citations

This map shows the geographic impact of Nancy Brewig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Brewig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Brewig more than expected).

Fields of papers citing papers by Nancy Brewig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Brewig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Brewig. The network helps show where Nancy Brewig may publish in the future.

Co-authorship network of co-authors of Nancy Brewig

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Brewig. A scholar is included among the top collaborators of Nancy Brewig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Brewig. Nancy Brewig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Parente‐Pereira, Ana C., Hilary Shmeeda, Lynsey M. Whilding, et al.. (2014). Adoptive Immunotherapy of Epithelial Ovarian Cancer with Vγ9Vδ2 T Cells, Potentiated by Liposomal Alendronic Acid. The Journal of Immunology. 193(11). 5557–5566. 47 indexed citations
2.
Maine, Christian J., Nor Haslinda Abd Aziz, Jayanta Chatterjee, et al.. (2013). Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer. Cancer Immunology Immunotherapy. 63(3). 215–224. 100 indexed citations
3.
Parente‐Pereira, Ana C., Lynsey M. Whilding, Nancy Brewig, et al.. (2013). Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with Carboplatin. The Journal of Immunology. 191(5). 2437–2445. 49 indexed citations
4.
Saso, Srdjan, Sadaf Ghaem‐Maghami, Jayanta Chatterjee, et al.. (2011). Immunology of Uterine Transplantation: A Review. Reproductive Sciences. 19(2). 123–134. 6 indexed citations
5.
Ritter, Uwe, et al.. (2010). Efficient control of Leishmania and Strongyloides despite partial suppression of nematode‐induced Th2 response in co‐infected mice. Parasite Immunology. 33(4). 226–235. 11 indexed citations
6.
Brewig, Nancy, Adrien Kissenpfennig, Bernard Malissen, et al.. (2009). Priming of CD8+ and CD4+ T Cells in Experimental Leishmaniasis Is Initiated by Different Dendritic Cell Subtypes. The Journal of Immunology. 182(2). 774–783. 77 indexed citations
7.
Horst, Andrea Kristina, Thomas Bickert, Nancy Brewig, et al.. (2009). CEACAM1+ myeloid cells control angiogenesis in inflammation. Blood. 113(26). 6726–6736. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026